Bioxytran, Inc. (OTCQB: BIXT)

Bioxytran, Inc. (OTCQB: BIXT)

Emerging Growth Conference

54 года назад

100 Просмотров

Bioxytran, Inc. (OTCQB: BIXT) is a clinical stage biotechnology company developing novel therapies targeting the treatment of significant unmet medical needs in virology, degenerative disease, and hypoxia.

Keynote speakers: Dr. David Platt, CEO & Mike Sheikh, Executive Vice President Business Development
Ссылки и html тэги не поддерживаются


Комментарии:

@swordman440
@swordman440 - 07.12.2024 23:13

Would anyone invest after watching this?? Are the other execs at this company similar?? GEEZ

Ответить